Perfil neuropsicológico de la degeneración lobar frontotemporal
DOI:
https://doi.org/10.23938/ASSN.0056Palabras clave:
Demencia frontotemporal. Neuropsicología. Dominios cognitivos. Parkinsonismos. Test neuropsicológico.Resumen
La degeneración lobar frontotemporal engloba tres síndromes diferentes, que comparten características clínicas y patológicas comunes, dificultando así su diagnóstico en estadios iniciales. Se incluyen en este grupo las tres variantes de la demencia frontotemporal, el síndrome corticobasal y el síndrome de parálisis supranuclear progresiva. Se ha llevado a cabo una revisión del perfil neuropsicológico de cada uno de los síndromes, que permita clarificar las características fundamentales que los definen y ayudar a diferenciarlos de otras demencias.
Se ha hecho una revisión de los diferentes trabajos publicados en la literatura al respecto, describiendo las características clínicas, patológicas y los hallazgos de imagen fundamentales de cada entidad para describir de manera exhaustiva los hallazgos en los diferentes dominios neuropsicológicos y su progresión.
Aunque existe un solapamiento entre los síndromes que conforman la degeneración lobar frontotemporal, la comparación del perfil neuropsicológico de las mismas entre sí y frente a otras demencias permite establecer características propias de su perfil neuropsicológico para llevar a cabo un diagnóstico diferencial.
Descargas
Citas
1. SIEBEN A, VAN LANGENHOVE T, ENGELBORGHS S, MARTIN JJ, BOON P, CRAS P et al. The genetics and neuropathology of frontotemporal lobar degeneration. Acta Neuropathol 2012; 124: 353-372.
https://doi.org/10.1007/s00401-012-1029-x
2. MACKENZIE IR, NEUMANN M, BIGIO EH, CAIRNS NJ, ALAFUZOFF I, KRIL J et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 2009; 117: 15-18.
https://doi.org/10.1007/s00401-008-0460-5
3. MACKENZIE IR, NEUMANN M, BIGIO EH, CAIRNS NJ, ALAFUZOFF I, KRIL J et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 2010; 119: 1-4.
https://doi.org/10.1007/s00401-009-0612-2
4. HALLIDAY G, BIGIO EH, CAIRNS NJ, NEUMANN M, MACKENZIE IR, MANN DM. Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects. Acta Neuropathol 2012; 124: 373-382.
https://doi.org/10.1007/s00401-012-1030-4
5. ROHRER JD, LASHLEY T, SCHOTT JM, WARREN JE, MEAD S, ISAACS AM et al. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 2011; 134: 2565-2581.
https://doi.org/10.1093/brain/awr198
6. TAIPA R, PINHO J, MELO-PIRES M. Clinico-pathological correlations of the most common neurodegenerative dementias. Front Neurol 2012; 3: 68.
https://doi.org/10.3389/fneur.2012.00068
7. ESPAY AJ, LITVAN I. Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci 2011; 45: 343-349.
https://doi.org/10.1007/s12031-011-9632-1
8. YOSHIZAWA H, VONSATTEL JP, HONIG LS. Presenting neuropsychological testing profile of autopsy-confirmed frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2013; 36: 279-289.
https://doi.org/10.1159/000353860
9. RASCOVSKY K, HODGES JR, KNOPMAN D, MENDEZ MF, KRAMER JH, NEUHAUS J et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456-2477.
https://doi.org/10.1093/brain/awr179
10. HODGES JR, DAVIES RR, XUEREB JH, CASEY B, BROE M, BAK TH et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399-406.
https://doi.org/10.1002/ana.20203
11. SNOWDEN JS, HU Q, ROLLINSON S, HALLIWELL N, ROBINSON A, DAVIDSON YS et al. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathol 201; 122: 99-110.
https://doi.org/10.1007/s00401-011-0816-0
12. AGOSTA F, CANU E, SARRO L, COMI G, FILIPPI M. Neuroimaging findings in frontotemporal lobar degeneration spectrum of disorders. Cortex 2012; 48: 389-413.
https://doi.org/10.1016/j.cortex.2011.04.012
13. PAN PL, SONG W, YANG J, HUANG R, CHEN K, GONG QY et al. Gray matter atrophy in behavioral variant frontotemporal dementia: a meta-analysis of voxel-based morphometry studies. Dement Geriatr Cogn Disord 2012; 33: 141-148.
https://doi.org/10.1159/000338176
14. FRANCESCHI M, ANCHISI D, PELATI O, ZUFFI M, MATARRESE M, MORESCO RM et al. Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Ann Neurol 2005; 57: 216-225.
https://doi.org/10.1002/ana.20365
15. RASCOVSKY K, SALMON DP, HO GJ, GALASKO D, PEAVY GM, HANSEN LA et al. Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology 2002; 58: 1801-1808.
https://doi.org/10.1212/WNL.58.12.1801
16. LIBON DJ, XIE SX, MOORE P, FARMER J, ANTANI S, MCCAWLEY G et al. Patterns of neuropsychological impairment in frontotemporal dementia. Neurolog 2007; 68: 369-375.
https://doi.org/10.1212/01.wnl.0000252820.81313.9b
17. GIOVAGNOLI AR, ERBETTA A, REATI F, BUGIANI O. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance. Neuropsychologia 2008; 46: 1495-1504.
https://doi.org/10.1016/j.neuropsychologia.2007.12.023
18. KRAMER JH, JURIK J, SHA SJ, RANKIN KP, ROSEN HJ, JOHNSON JK et al. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol 2003; 16: 211-218.
https://doi.org/10.1097/00146965-200312000-00002
19. CAINE D, PATTERSON K, HODGES JR, HEARD R, HALLIDAY G. Severe anterograde amnesia with extensive hippocampal degeneration in a case of rapidly progressive frontotemporal dementia. Neurocase 2001; 7: 57-64.
https://doi.org/10.1093/neucas/7.1.57
20. GRAHAM A, DAVIES R, XUEREB J, HALLIDAY G, KRIL J, CREASEY H et al. Pathologically proven frontotemporal dementia presenting with severe amnesia. Brain. 2005; 128: 597-605.
https://doi.org/10.1093/brain/awh348
21. HORNBERGER M, PIGUET O. Episodic memory in frontotemporal dementia: a critical review. Brain 2012; 135: 678-692.
https://doi.org/10.1093/brain/aws011
22. PERRY RJ, HODGES JR. Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease. Neurology 2000; 54: 2277-2284.
https://doi.org/10.1212/WNL.54.12.2277
23. LAGARDE J, VALABREGUE R, CORVOL JC, PINEAU F, LE BER I, VIDAILHET M et al. Are frontal cognitive and atrophy patterns different in PSP and bvFTD? A comparative neuropsychological and VBM Study. PLoS One 2013; 8: e80353.
https://doi.org/10.1371/journal.pone.0080353
24. MENDEZ MF, MCMURTRAY AM, LICHT EA, SAUL RE. Frontal-executive versus posterior-perceptual mental status deficits in early-onset dementias. Am J Alzheimers Dis Other Demen 2009; 24: 220-227.
https://doi.org/10.1177/1533317509332626
25. PERRI R, KOCH G, CARLESIMO GA, SERRA L, FADDA L, PASQUALETTI P et al. Alzheimer's disease and frontal variant of frontotemporal dementia-- a very brief battery for cognitive and behavioural distinction. J Neurol 2005; 252: 1238-1244.
https://doi.org/10.1007/s00415-005-0849-1
26. THOMPSON JC, STOPFORD CL, SNOWDEN JS, NEARY D. Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2005; 7: 920-927.
https://doi.org/10.1136/jnnp.2003.033779
27. GORNO-TEMPINI ML, HILLIS AE, WEINTRAUB S, KERTESZ A, MENDEZ M, CAPPA SF et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76: 1006-1014.
https://doi.org/10.1212/WNL.0b013e31821103e6
28. HODGES JR, PATTERSON K. Semantic dementia: a unique clinicopathological syndrome. Lancet Neurol 2007; 6: 1004-1014.
https://doi.org/10.1016/S1474-4422(07)70266-1
29. ROHRER JD, WARREN JD, MODAT M, RIDGWAY GR, DOUIRI A, ROSSOR MN et al. Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology 2009; 72: 1562-1569.
https://doi.org/10.1212/WNL.0b013e3181a4124e
30. DIEHL J, GRIMMER T, DRZEZGA A, RIEMENSCHNEIDER M, FORSTL H, KURZ A. Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study. Neurobiol Aging 2004; 25: 1051-1056.
https://doi.org/10.1016/j.neurobiolaging.2003.10.007
31. DESGRANGES B, MATUSZEWSKI V, PIOLINO P, CHETELAT G, MEZENGE F, LANDEAU B et al. Anatomical and functional alterations in semantic dementia: a voxel-based MRI and PET study. Neurobiol Aging 2007; 28: 1904-1913.
https://doi.org/10.1016/j.neurobiolaging.2006.08.006
32. HODGES JR, PATTERSON K, OXBURY S, FUNNELL E. SEMANTIC DEMENTIA. Progressive fluent aphasia with temporal lobe atrophy. Brain 1992; 115: 1783-1806.
https://doi.org/10.1093/brain/115.6.1783
33. HODGES JR, PATTERSON K, WARD R, GARRARD P, BAK T, PERRY R et al. The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study. Neuropsychology 1999; 13: 31-40.
https://doi.org/10.1037/0894-4105.13.1.31
34. KERTESZ A, MARTINEZ-LAGE P, DAVIDSON W, MUNOZ DG. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 2000; 55: 1368-1375.
https://doi.org/10.1212/WNL.55.9.1368
35. KERTESZ A, MCMONAGLE P, BLAIR M, DAVIDSON W, MUNOZ DG. The evolution and pathology of frontotemporal dementia. Brain 2005; 128: 1996-2005.
https://doi.org/10.1093/brain/awh598
36. JOSEPHS KA, HODGES JR, SNOWDEN JS, MACKENZIE IR, NEUMANN M, MANN DM et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 2011; 122: 137-153.
https://doi.org/10.1007/s00401-011-0839-6
37. GROSSMAN M, RHEE J, MOORE P. Sentence processing in frontotemporal dementia. Cortex 2005; 41: 764-777.
https://doi.org/10.1016/S0010-9452(08)70295-8
38. LITVAN I, AGID Y, CALNE D, CAMPBELL G, DUBOIS B, DUVOISIN RC et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurolog 1996; 47: 1-9.
https://doi.org/10.1212/WNL.47.1.1
39. DICKSON DW, AHMED Z, ALGOM AA, TSUBOI Y, JOSEPHS KA. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 2010; 23: 394-400.
https://doi.org/10.1097/WCO.0b013e32833be924
40. YOKOTA O, DAVIDSON Y, BIGIO EH, ISHIZU H, TERADA S, ARAI T et al. Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol 2010; 120: 55-66.
https://doi.org/10.1007/s00401-010-0702-1
41. TEUNE LK, BARTELS AL, DE JONG BM, WILLEMSEN AT, ESHUIS SA, DE VRIES JJ et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 2010; 25: 2395-2404.
https://doi.org/10.1002/mds.23291
42. MASCALCHI M, VELLA A, CERAVOLO R. Movement disorders: role of imaging in diagnosis. J Magn Reson Imaging 2012; 35: 239-256.
https://doi.org/10.1002/jmri.22825
43. KEPE V, BORDELON Y, BOXER A, HUANG SC, LIU J, THIEDE FC et al. PET imaging of neuropathology in tauopathies: progressive supranuclear palsy. J Alzheimers Dis 2013; 36:145-153.
https://doi.org/10.3233/JAD-130032
44. BORRONI B, TURLA M, BERTASI V, AGOSTI C, GILBERTI N, PADOVANI A. Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes. Arch Gerontol Geriatr 2008; 47: 53-61.
https://doi.org/10.1016/j.archger.2007.07.005
45. YATABE Y, HASHIMOTO M, KANEDA K, HONDA K, OGAWA Y, YUUKI S et al. Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic. Psychogeriatrics 2011; 11: 54-59.
https://doi.org/10.1111/j.1479-8301.2010.00352.x
46. STEELE JC, RICHARDSON JC, OLSZEWSKI J. PROGRESSIVE SUPRANUCLEAR PALSY. A Heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964; 10: 333-359.
https://doi.org/10.1001/archneur.1964.00460160003001
47. ALBERT ML, FELDMAN RG, WILLIS AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974; 37: 121-130.
https://doi.org/10.1136/jnnp.37.2.121
48. LITVAN I. Cognitive disturbances in progressive supranuclear palsy. J Neural Transm Suppl 1994; 42: 69-78.
https://doi.org/10.1007/978-3-7091-6641-3_6
49. BAK TH, ROGERS TT, CRAWFORD LM, HEARN VC, MATHURANATH PS, HODGES JR. Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry. 2005; 76 : 420-422.
https://doi.org/10.1136/jnnp.2003.029595
50. BEATTY WW, SCOTT JG, WILSON DA, PRINCE JR, WILLIAMSON DJ. Memory deficits in a demented patient with probable corticobasal degeneration. J Geriatr Psychiatry Neurol 1995; 8: 132-136.
https://doi.org/10.1177/089198879500800212
51. PILLON B, DEWEER B, MICHON A, MALAPANI C, AGID Y, DUBOIS B. Are explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits? Comparison with Alzheimer's, Parkinson's, and Huntington's diseases. Neurology 1994; 44: 1264-1270.
https://doi.org/10.1212/WNL.44.7.1264
52. MAGHERINI A, LITVAN I. Cognitive and behavioral aspects of PSP since Steele, Richardson and Olszewski's description of PSP 40 years ago and Albert's delineation of the subcortical dementia 30 years ago. Neurocase 2005; 11: 250-262.
https://doi.org/10.1080/13554790590962979
53. BORRONI B, ALBERICI A, AGOSTI C, COSSEDDU M, PADOVANI A. Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy. Int Psychogeriatr 2009; 21: 463-468.
https://doi.org/10.1017/S1041610209008862
54. DUBOIS B, SLACHEVSKY A, LITVAN I, PILLON B. The FAB: a frontal assessment battery at bedside. Neurology 2000; 12; 55: 1621-1626.
https://doi.org/10.1212/WNL.55.11.1621
55. SOLIVERI P, MONZA D, PARIDI D, CARELLA F, GENITRINI S, TESTA D et al. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2000; 69: 313-318.
https://doi.org/10.1136/jnnp.69.3.313
56. SOLIVERI P, PIACENTINI S, GIROTTI F. Limb apraxia in corticobasal degeneration and progressive supranuclear palsy. Neurology 2005; 64: 448-453.
https://doi.org/10.1212/01.WNL.0000150732.92567.BA
57. DUBOIS B, PILLON B, LEGAULT F, AGID Y, LHERMITTE F. Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease. Arch Neurol 1988; 45: 1194-1199.
https://doi.org/10.1001/archneur.1988.00520350032011
58. PIRTOSEK Z, JAHANSHAHI M, BARRETT G, LEES AJ. Attention and cognition in bradykinetic-rigid syndromes: an event-related potential study. Ann Neurol 2001; 50: 567-573.
https://doi.org/10.1002/ana.1221
59. PAVIOUR DC, WINTERBURN D, SIMMONDS S, BURGESS G, WILKINSON L, FOX NC et al. Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. Neurocase 2005; 11: 274-282.
https://doi.org/10.1080/13554790590962933
60. JOSEPHS KA, BOEVE BF, DUFFY JR, SMITH GE, KNOPMAN DS, PARISI JE et al. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase 2005; 11: 283-296.
https://doi.org/10.1080/13554790590963004
61. LEE SE, RABINOVICI GD, MAYO MC, WILSON SM, SEELEY WW, DEARMOND SJ et al. Clinicopathological correlations in corticobasal degeneration. Ann Neurol 2011; 70: 327-340.
https://doi.org/10.1002/ana.22424
62. BOEVE BF, MARAGANORE DM, PARISI JE, AHLSKOG JE, GRAFF-RADFORD N, CASELLI RJ et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999; 53: 795-800.
https://doi.org/10.1212/WNL.53.4.795
63. CHAND P, GRAFMAN J, DICKSON D, ISHIZAWA K, LITVAN I. Alzheimer's disease presenting as corticobasal syndrome. Mov Disord 2006; 21: 2018-2022.
https://doi.org/10.1002/mds.21055
64. TARTAGLIA MC, SIDHU M, LALUZ V, RACINE C, RABINOVICI GD, CREIGHTON K et al. Sporadic corticobasal syndrome due to FTLD-TDP. Acta Neuropathol 2010; 119: 365-374.
https://doi.org/10.1007/s00401-009-0605-1
65. LITVAN I, BHATIA KP, BURN DJ, GOETZ CG, LANG AE, MCKEITH I et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003; 18: 467-486.
https://doi.org/10.1002/mds.10459
66. ARMSTRONG MJ, LITVAN I, LANG AE, BAK TH, BHATIA KP, BORRONI B et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80: 496-503.
https://doi.org/10.1212/WNL.0b013e31827f0fd1
67. LITVAN I, CUMMINGS JL, MEGA M. Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry 1998; 65: 717-721.
https://doi.org/10.1136/jnnp.65.5.717
68. BERGERON C, POLLANEN MS, WEYER L, BLACK SE, LANG AE. Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol 1996; 40: 893-900.
https://doi.org/10.1002/ana.410400611
69. GRIMES DA, LANG AE, BERGERON CB. Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 1999; 53: 1969-1974.
https://doi.org/10.1212/WNL.53.9.1969
70. LANG AE, BERGERON C, POLLANEN MS, ASHBY P. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology 1994; 44: 1436-1440.
https://doi.org/10.1212/WNL.44.8.1436
71. BOEVE BF, LANG AE, LITVAN I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003; 54S: 15-19.
https://doi.org/10.1002/ana.10570
72. PILLON B, BLIN J, VIDAILHET M, DEWEER B, SIRIGU A, DUBOIS B et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995; 45: 1477-1483.
https://doi.org/10.1212/WNL.45.8.1477
73. WENNING GK, LITVAN I, JANKOVIC J, GRANATA R, MANGONE CA, MCKEE A et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998; 64: 184-189.
https://doi.org/10.1136/jnnp.64.2.184
74. FRISONI GB, PIZZOLATO G, ZANETTI O, BIANCHETTI A, CHIERICHETTI F, TRABUCCHI M. Corticobasal degeneration: neuropsychological assessment and dopamine D2 receptor SPECT analysis. Eur Neurol 1995; 35: 50-54.
https://doi.org/10.1159/000117090
75. GROSSMAN M, D'ESPOSITO M, HUGHES E, ONISHI K, BIASSOU N, WHITE-DEVINE T et al. Language comprehension profiles in Alzheimer's disease, multi-infarct dementia, and frontotemporal degeneration. Neurology 1996; 47: 183-189.
https://doi.org/10.1212/WNL.47.1.183
76. MCMONAGLE P, BLAIR M, KERTESZ A. Corticobasal degeneration and progressive aphasia. Neurology 2006; 67: 1444-1451.
https://doi.org/10.1212/01.wnl.0000240215.43492.01
77. KERTESZ A. Corticobasal degeneration. J Neurol Neurosurg Psychiatry 2000; 68: 275.
https://doi.org/10.1136/jnnp.68.3.275
78. ROSEN HJ, HARTIKAINEN KM, JAGUST W, KRAMER JH, REED BR, CUMMINGS JL et al. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology 2002; 58: 1608-1615.
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2015 Anales del Sistema Sanitario de Navarra
Esta obra está bajo una licencia internacional Creative Commons Atribución-CompartirIgual 4.0.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
